Related Experiment Videos
[Progress in laboratory tests of connective tissue diseases]
Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 1, 1989
Summary
Autoantibodies against nuclear antigens are key indicators of connective tissue diseases like SLE, PSS, and PM. Specific autoantibodies correlate with distinct clinical features and disease manifestations.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Context:
- Connective tissue diseases (CTDs) are characterized by the presence of autoantibodies.
- Systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis (PM) are examples of CTDs.
- Autoantibodies target various nuclear and non-nuclear antigens.
Purpose:
- To investigate the prevalence and clinical significance of specific autoantibodies in patients with connective tissue diseases.
- To correlate autoantibody profiles with specific clinical manifestations and disease subtypes.
Summary:
- High titers of anti-double-strand DNA antibodies were observed in SLE patients.
- Anti-U1RNP antibodies correlated with Raynaud's phenomenon and finger erythema in SLE.
- Anti-Scl-70 antibodies were found in 52% of PSS patients.
- Anti-Jo-1 antibodies were associated with PM and pulmonary fibrosis.
- A novel autoantibody precipitating 7SL RNA was identified in two PM patients.
Impact:
- Establishes autoantibody profiles as diagnostic and prognostic biomarkers in CTDs.
- Highlights the heterogeneity of autoantibody expression across different CTDs.
- Identifies potential new autoantigens for further research in autoimmune diseases.